Clinical Trial

Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib

Study acronym: WEFITTER
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 26, 2024 (before its estimated March 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Combining a fitness tracker technology with real-time patient-reported outcome monitoring associated with interventions through a health care app is a novel strategy to evaluate metastatic breast cancer patients using Palbociclib and endocrine treatment.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-03-03; most recent amendment 2024-08-23.
Status change: Not Yet Recruiting → Recruiting 2022-08-08
Trial Details
NCT Number NCT05277935
Lead Sponsor Beneficência Portuguesa de São Paulo
Conditions Breast Neoplasm Female, Quality of Life
Enrollment 68 participants
Start Date 2022-04-22
Primary Completion 2025-03-01 (estimated)
Study Completion 2025-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-26